Literature DB >> 8492223

A novel monoclonal antibody (FUN-1) identifies an activation antigen in cells of the B-cell lineage and Reed-Sternberg cells.

Y Nozawa1, E Wachi, K Tominaga, M Abe, H Wakasa.   

Abstract

The characterization of a new monoclonal antibody (MoAb) recognizing a human B-cell activation antigen, designated FUN-1, is described in this paper. Immunoprecipitation revealed that FUN-1 recognizes an antigen with a molecular weight (MW) of 75kD. FUN-1 reacts with pokeweed mitogen-activated B lymphocytes and monocytes of peripheral blood, but not with unstimulated lymphocytes or granulocytes. It also reacts with large lymphoid cells in germinal centres, Epstein-Barr virus-transformed B cell lines, large B-cell lymphomas, Ki-1-positive anaplastic large-cell lymphomas, and Reed-Sternberg cells of Hodgkin's disease, but not with Concanavalin A-activated T cells, acute lymphoblastic leukaemias, T-cell lymphomas, or low-grade B-cell leukaemias. These findings indicate that FUN-1 recognizes a previously unreported B-cell activation antigen. This MoAb appears to be useful for the study of maturation and differentiation in the B-cell lineage as well as for the immunohistochemical diagnosis of B-cell lymphomas and Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8492223     DOI: 10.1002/path.1711690306

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  5 in total

1.  Human CTLA-4 is expressed in situ on T lymphocytes in germinal centers, in cutaneous graft-versus-host disease, and in Hodgkin's disease.

Authors:  K Vandenborre; J Delabie; M A Boogaerts; R De Vos; K Lorré; C De Wolf-Peeters; P Vandenberghe
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

2.  Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis.

Authors:  M K Racke; D E Scott; L Quigley; G S Gray; R Abe; C H June; P J Perrin
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

3.  Activation of human dendritic cells through CD40 cross-linking.

Authors:  C Caux; C Massacrier; B Vanbervliet; B Dubois; C Van Kooten; I Durand; J Banchereau
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

4.  B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.

Authors:  C Caux; B Vanbervliet; C Massacrier; M Azuma; K Okumura; L L Lanier; J Banchereau
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

5.  B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease.

Authors:  W C Vooijs; H G Otten; M van Vliet; A J van Dijk; R A de Weger; M de Boer; H Bohlen; A Bolognesi; L Polito; G C de Gast
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.